Австралия - английски - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - insulin aspart, quantity: 100 u/ml - injection, solution - excipient ingredients: glycerol; phenol; metacresol; zinc; dibasic sodium phosphate dihydrate; arginine; hydrochloric acid; sodium hydroxide; water for injections; nicotinamide - treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Австралия - английски - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - insulin aspart, quantity: 100 u/ml - injection, solution - excipient ingredients: glycerol; phenol; metacresol; zinc; dibasic sodium phosphate dihydrate; arginine; hydrochloric acid; sodium hydroxide; water for injections; nicotinamide - treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - glyceryl trinitrate 5 mg/ml - solution for injection - 50 mg/10ml - active: glyceryl trinitrate 5 mg/ml excipient: ethanol propylene glycol water for injection

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

beaumont pharma ltd - glyceryl trinitrate - solution for infusion - 1mg/1ml

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

beaumont pharma ltd - glyceryl trinitrate - solution for infusion - 1mg/1ml

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - insulin lispro 100 u/ml;   - solution for injection - 100 u/ml - active: insulin lispro 100 u/ml   excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid metacresol sodium hydroxide water for injection zinc oxide - for the treatment of patients with type 1 (iddm) and type 2 (niddm) diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - insulin lispro 100 u/ml;   - solution for injection - 100 u/ml - active: insulin lispro 100 u/ml   excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid metacresol sodium hydroxide water zinc oxide - for the treatment of patients with type 1 (iddm) and type 2 (niddm) diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - soya oil 10%{relative};  ;   - solution for infusion - 10 % - active: soya oil 10%{relative}     excipient: egg lecithin glycerol water for injection - part of the intravenous diet in all parenteral nutrition indications including: - preoperative and postoperative nutritional disturbances where an improved nitrogen balance is required; - nutritional disorders or disturbances of nitrogen balance due to inadequate or failing intestinal absorption caused by tumours in the gastrointestinal tract, acute or chronic intestinal diseases (peritonitis, ulcerative colitis, terminal ileitis); - burns, to reduce the frequently excessive nitrogen losses; - prolonged unconsciousness, eg following cranial trauma or poisoning in cases where enteral feeding is inappropriate or impossible; - impaired renal function where a concentrated source of energy may be indicated to reduce protein breakdown; - cachexia and - patients with essential fatty acid deficiency who cannot maintain or restore a normal essential fatty acid pattern by oral intake.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - insulin detemir 100 u/ml - solution for injection - 100 u/ml - active: insulin detemir 100 u/ml excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol sodium chloride sodium hydroxide water for injection zinc as acetate and insulin detemir crystals - for the treatment of diabetes mellitus

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - insulin detemir 100 u/ml - solution for injection - 100 u/ml - active: insulin detemir 100 u/ml excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol sodium chloride sodium hydroxide water for injection zinc as acetate and insulin detemir crystals - for the treatment of diabetes mellitus